RYTM
NASDAQStockRhythm Pharmaceuticals, Inc.
$92.61+2.52 (+2.80%)
52-Week Range
$46.95
$117.62
Key Stats
Market Cap
6.3B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.15
Volume
396.9K
Avg Volume
834.5K
Performance
1M
-11.39%
3M
-19.73%
6M
-5.08%
YTD
-13.20%
1Y
+77.61%
3Y
+376.98%
5Y
+245.00%
Price Chart
ETF Exposure
RYTM is held by 94 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| MEDI | Harbor Health Care ETF (MEDI) | 3.84% |
| HAPS | Harbor Human Capital Factor US Small Cap ETF (HAPS) | 1.98% |
| OZEM | Roundhill Investments - GLP-1 & Weight Loss ETF | 1.42% |
| BBP | Virtus Biotech ETF | 1.25% |
| GURU | Global X - Guru Index ETF | 1.25% |
| XBI | State Street SPDR S&P Biotech ETF | 1.08% |
| FSML | Franklin Small Cap Enhanced ETF | 1.07% |
| HART | NYLI Healthy Hearts ETF | 0.77% |
| GDOC | Goldman Sachs Future Health Care Equity ETF | 0.71% |
| HEAL.L | iShares Healthcare Innovation UCITS ETF | 0.64% |
| FNY | First Trust Mid Cap Growth AlphaDEX Fund | 0.63% |
| DWAS | Invesco Dorsey Wright SmallCap Momentum ETF | 0.63% |
| SGRW | Harbor Active Small Cap Growth ETF (SGRW) | 0.61% |
| GSC | Goldman Sachs Small Cap Equity ETF | 0.60% |
| SCDS | JPMorgan Fundamental Data Science Small Core ETF | 0.53% |
| MMSC | First Trust Multi-Manager Small Cap Opportunities ETF | 0.53% |
| IBB | iShares Biotechnology ETF | 0.51% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.47% |
| HELX | Franklin Genomic Advancements ETF | 0.42% |
| IWO | iShares Russell 2000 Growth ETF | 0.39% |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 0.36% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.34% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.32% |
| FNX | First Trust Mid Cap Core AlphaDEX Fund | 0.31% |
| STXK | Strive Small-Cap ETF | 0.30% |
| BBSC | JPMorgan BetaBuilders U.S. Small Cap Equity ETF | 0.28% |
| BKSE | BNY Mellon US Small Cap Core Equity ETF | 0.28% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.26% |
| PWS | Pacer WealthShield ETF | 0.24% |
| JHSC | John Hancock Investments - Multifactor Small Cap ETF | 0.22% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.22% |
| VBK | Vanguard Small-Cap Growth ETF | 0.21% |
| FAD | First Trust Multi Cap Growth AlphaDEX Fund | 0.19% |
| EHLS | Even Herd Long Short ETF | 0.19% |
| USVM | VictoryShares US Small Mid Cap Value Momentum ETF | 0.19% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.19% |
| FESM | FIDELITY ENHANCED SMALL CAP ETF | 0.18% |
| PQSG | PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF | 0.18% |
| VTWO | Vanguard Russell 2000 ETF | 0.17% |
| ISCG | iShares Morningstar Small-Cap Growth ETF | 0.17% |
| JKK | iShares Morningstar Small-Cap Growth ETF | 0.17% |
| RSSL | Global X - Russell 2000 ETF | 0.17% |
| IWM | iShares Russell 2000 ETF | 0.17% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.14% |
| FTKI | First Trust Small Cap BuyWrite Income ETF | 0.13% |
| TMSL | T. Rowe Price Small-Mid Cap ETF | 0.12% |
| SMLF | iShares U.S. Small-Cap Equity Factor ETF | 0.12% |
| NXTI | Simplify NEXT Intangible Core Index ETF | 0.12% |
| UWM | ProShares - Ultra Russell2000 | 0.11% |
| URTY | ProShares - UltraPro Russell2000 | 0.10% |
Page 1 of 2Next
About RYTM ETF Exposure
Rhythm Pharmaceuticals, Inc. (RYTM) is held by 94 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 6.3B, RYTM is a widely held institutional stock. The stock currently trades at $92.61. Investors can gain exposure to RYTM through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold RYTM, sorted by portfolio weight.